Hormone-associated cancer: Mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 3, 1997, Pages 565-569

  Liehr, Joachim G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Breast cancer; Estradiol; Estrogen induced cancer; Hamster kidney

Indexed keywords

ESTROGEN; FREE RADICAL;

BREAST CANCER; CANCER RISK; CARCINOGENESIS; CELL TRANSFORMATION; CONFERENCE PAPER; DNA DAMAGE; HUMAN; KIDNEY CANCER; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 0030986245     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s3565     Document Type: Conference Paper

References (54)

1. Greenwald P, Caputo TA, Wolfgang PE. Endometrial cancer after menopausal use of estrogens. Obstet Gynecol 50:239-243 (1977).
2. Siiteri PK, Nisker JA, Hammond GL. Hormonal basis of risk factors for breast and endometrial cancer. In: Hormones and Cancer (Iacobelli S, King RJB, Lindner HR, Lippman ME, eds). New York:Raven Press, 1980;499-505.
3. Key TJA, Pike MC. The dose-effect relationship between "unopposed" estrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57:205-212 (1988).
4. MacMahon B. Risk factors for endometrial cancer. Gynecol Oncol 2:122-129 (1974).
5. Key TJA, Pike MC. The role of estrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24:29-43 (1988).
6. Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer. Science 244:1131-1138 (1991).
7. Hulka BS, Liu ET, Lininger RA. Steroid hormones and risk of breast cancer. Cancer 74(3):1111-1124 (1993).
8. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. The use of estrogens and progestins and the risk of breast cancer in post-menopausal women. N Engl J Med 332:1589-1593 (1995).
9. Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev 11:266-301 (1990).
10. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS. A prospective study of endogenous estrogens and breast cancer in post-menopausal women. J Natl Cancer Inst 87:190-197 (1995).
11. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hämäläinen E. Estrogen metabolism and excretion in oriental and caucasian women. J Natl Cancer Inst 86:1076-1082 (1994).
12. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science 259:633-638 (1993).
13. Newbold RR, Bullock BC, McLachlan JA. Uterine adenocarcinoma in mice following developmental treatment with estrogen. Cancer Res 50:7677-7681 (1990).
14. Walker BE. Animal models of prenatal exposure to diethylsilbestrol. In: Perinatal and Multigeneration Carcinogenesis (Napalkov NP, Rice JM, Tomatis L, Yamasaki H, eds). IARC Scientific Publications No 96. Lyon:International Agency for Cancer Research, 1989;349-364, 436.
15. Clifton KH, Meyer RK. Mechanism of anterior pituitary tumor induction by oestrogen. Anat Rec 125:65-81 (1956).
16. Walker BE, Kurth LA. Pituitary tumors in mice exposed prenatally to diethylstilbestrol. Cancer Res 53:1546-1549 (1993).
17. Leav I, Merk FB, Kwan PW, Ho SM. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 15:23-40 (1989).
18. Jones LA, Pacillas-Verjan R. Transplantability and sex steroid hormone responsiveness of cervicovaginal tumors derived from female BALB/cCrgl mice neonatally treated with ovarian steroids. Cancer Res 39:2591-2594 (1980).
19. Huseby RA. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse. Cancer Res 40:1006-1013 (1980).
20. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans. Suppl 7. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1-42. Lyon: International Agency for Research on Cancer, 1987; 272-310, 440.
21. Kirkman H. Estrogen-induced tumors of the kidney in the Syrian hamster. III: Growth characteristics in the Syrian hamster. Natl Cancer Inst Monogr 1:1-57 (1959).
22. Sirbasku D, Kirkland WL. Control of cell growth. IV: Growth properties of a new cell line established from an estrogen-dependent kidney tumor of the Syrian hamster. Endocrinology 98:1260-1272 (1976).
23. Oberley TD, Lauchner LJ, Pugh TD, Gonzalez A, Goldfarb S, Li SA, Li JJ. Specific estrogen-induced cell proliferation of cultured Syrian hamster renal proximal tubular cells in serum-free chemically defined media. Proc Natl Acad Sci USA 86:2107-2111 (1989).
24. Liehr JG, Purdy RH, Baran JS, Nutting ER, Colton F, Randerath E, Randerath K. Correlation of aromatic hydroxylation of 11β-substituted estrogens with neoplastic transformation in vitro but not with in vivo tumor induction by these hormones. Cancer Res 47:2583-2588 (1987).
25. Liehr JG. 2-Fluoroestradiol: separation of estrogenicity from carcinogeneicity. Mol Pharmacol 23:278-281 (1983).
26. Slaunwhite WR, Kirdani RY, Sandberg AA. Metabolic aspects of estrogens in man. In: Handbook of Physiology, Section 7: Endocrinology. Vol II, Part 1 (Greep RO, Astwood EB, Geiger SR, eds). Washington:American Physiological Society, 1973;485-523.
27. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 57:237-257 (1993).
28. Weisz J, Bui QD, Roy D, Liehr JG. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: potential pathway of metabolic activation estrogens. Endocrinology 131:655-661(1992).
29. Paria BC, Chakraborty C, Dey SK. Catecholestrogen formation in mouse uterus and its role in implantion. Mol Cell Endocrinol 69:25-31 (1990).
30. Bui QD, Weisz J. Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase. Endocrinology 124:1085-1087 (1989).
31. Dwivedy I, Devanesan P, Cremonesi P, Rogan E, Cavalieri E. Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens. Chem Res Toxicol 5:828-833 (1992).
32. Ashburn SP, Han X, Liehr JG. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis. Mol Pharmacol 43:534-541 (1993).
33. Liehr JG, Ulubelen AA, Strobel HW. Cytochrome P-450-mediated redox cycling of estrogens. J Biol Chem 261: 16865-16870 (1986).
34. Roy D, Liehr JG. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. J Biol Chem 263:3646-3651 (1988).
35. Han X, Liehr JG. DNA single strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens. Hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 15:997-1000 (1994).
36. Han X, Liehr JG. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res 54:5155-5157 (1994).
37. Han X, Liehr JG. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 16:2571-2574 (1995).
38. Li Y, Trush MA, Yager JD. DNA damage caused by reactive oxygen species orginating from a copper-dependent oxidation of the 2-hydroxycatechol of estradiol. Carcinogenesis 15:1421-1427 (1994).
39. Wang MY, Liehr JG. Identification of fatty acid hydroperoxide cofactors in the cytochrome P450-mediated oxidation of estrogens to quinone metabolites: role and balance of lipid peroxides during estrogen-induced carcinogenesis. J Biol Chem 269:284-291 (1994).
40. Wang MY, Liehr JG. Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. Arch Biochem Biophys 316: 38-46 (1995).
41. Barnea ER, MacLusky NJ, Naftolin F. Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity. Steroids 41:643-656 (1983).
42. Spink DC, Hayes GL, Young NR, Christou M, Sutter TR, Jefcoate CR, Gierthy JF. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17β-estradiol 4-hydroxylase. J Steroid Biochem Mol Biol 51:251-258 (1994).
43. Liehr JG Ricci MJ. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93: 3294-3296 (1996).
44. Savas U, Bhattacharya KK, Christou M, Alexander DL, Jefcoate CR. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination, and tissue expression. J Biol Chem 269:14905-14911 (1994).
45. Sutter TR, Tang YM, Hayes CL, Wo YY, Jabs EW, Li X, Yin H, Cody CW, Greenlee WF. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269:13092-13099 (1994).
46. Liehr JG, Fang WF, Sirbasku DA, Ulubelen AA. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 24:353-356 (1986).
47. Malins DC, Holmes EH, Polissar NL, Gunselman SJ. The etiology of breast cancer. Characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 71:3036-3043 (1993).
48. Boyd NF, McGuire V. The possible role of lipid peroxidation in breast cancer risk. Free Rad Biol Med 10:185-190 (1991).
49. 2-propanodeoxyguanosine adducts in mammary gland DNA of humans and rats. Proc Am Assoc Cancer Res 36:139 (1995).
50. Wang M-Y, Dhingra K, Hittelmann WN, Liehr JG, de Andrade M, Li D. Lipid peroxidation-induced putative malon-dialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev 5:705-710 (1996).
51. Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, Lubin F, Marubini E, Modan B, Rohan T, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case control studies. J Natl Cancer Inst 82:561-569 (1990).
52. Liehr JG, Wheeler WJ. Inhibition of estrogen-induced renal carcinoma in Syrian hamsters by vitamin C. Cancer Res 43:4638-4642 (1983).
53. Nutter LM, Ngo EO, Abul-Hajj YJ. Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells. J Biol Chem 266:16380-16386 (1991).
54. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36:203-232 (1996).